Log In
BCIQ
Print this Print this
 

sevacizumab (BD0801) (APX003, SIM-BD0801)

  Manage Alerts
Collapse Summary General Information
Company Apexigen Inc.
DescriptionHumanized mAb directed against VEGF
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today